Objective: Evaluation of free radical scavenging activity of Berberine (BBR) in acetaminophen (AAP) induced liver injury. Study design: Experimental study. Place and Duration: Animal House, Isra University Hyderabad from October 2015 to March 2016. Methodology: A sample of 80 male Wistar rats was selected according to inclusion and exclusion criteria and was divided into a control and three experimental groups. Acetaminophen, N-acetyl cysteine (NAC) and BBR were administered in standard doses. Cardiac puncture collected blood samples after 18 hours of the post-experiment period. Liver function test, antioxidant enzymes, and malondialdehyde (MDA) were detected by ELISA assay kit (Fortress Diagnostics). The data was analyzed on Statistix 10.0 software (USA) at 95% CI (P≤ 0.05). Results: The BBR showed antioxidant and antiperoxidant activity against acetaminophen-induced liver injury. BBR treated animals showed increased serum and tissue SOD, GPX, CAT, and GSSH with a reduction in tissue MDA (p=0.0001). Liver injury ameliorating effect of BBR was superior to N-acetyl cysteine. Conclusion: The present study suggests Berberine protects against acetaminophen-induced liver injury by its free radical scavenging activity.
Introduction
Drug-induced liver injury (DILI), such as that caused by the acetaminophen, is not an uncommon toxicological problem encountered in the medical practice. In the case of severe toxicity, this results in severe liver injury, hepatocellular necrosis, and death. The liver microsome detoxifies many drugs and toxic agents. [1] Acute fulminant liver failure is the end results with hepatic encephalopathy, coagulopathies, electrolyte and acidbase imbalance and death. Acetaminophen (AAP) is used as an analgesic and antipyretic drug because of easy availability. It is an over-the-counter (OTC) product available in several formulations. [1, 2] In United States, over 60 million people use the AAP on a regular basis. [3] While its use in the developing countries is not registered. AAP is approved by FDA as safe in doses up to 4000 mg in 24 hours, so generally it is considered safe and nontoxic at regular doses. [4, 5] AAP is available in various formulations such as the liquid syrup, tablets, infusions, rectal suppositories and combination supplements as OTC. [3] The reactive oxygen species (ROS) generated by drug toxicity, are neutralized by in-built enzyme systems of the liver; such as the superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), and reduced glutathione (GSSH), and others. N-acetylcysteine (NAC) is a thiol-containing agent used since three decades as an antidote for AAP toxicity. [5, 6] Clinical efficacy of NAC is well established. Clinically it is utilized for the chronic obstructive pulmonary disease (COPD) and contrastinduced nephropathy. [6] [7] [8] Nowadays a growing interest has been found in herbal agents against DILI. Berberine (BBR) is one of herbal derivative used as OTC drug in China. The BBR is a plant isoquinoline alkaloid, traditionally used to treat infectious diarrhea. [10] The BBR is derived from the Rhizoma Coptidis Franch which is an indigenous Chinese herb. Rhizoma Coptidis Franch contains 5.2%-7.7% of berberine. It has been used for soothing of inflammatory reactions and treatment of diabetes mellitus (DM), and others. [10] [11] [12] Pleiotropic clinical effects of BBR have been reported such as use in liver disease, obesity [13] [14] [15] , dyslipidemia, and cardiac disorders, and others. [16, 17] The present study evaluated the free radical scavenging activity of Berberine in acetaminophen-induced liver injury in comparison to N-acetyl cysteine.
MATERIALS AND METHODS
The present experimental study was conducted, comprising a sample of 80 male Wistar rats, at the animal house of Isra University Hyderabad, Sindh. The study covered duration from October 2015 to March 2016. Animals belonged to the species produced originally by Charles River Breeding Laboratories, Brooklyn, Massachusetts, USA. They were housed at the Basic Medical Sciences Institute (BMSI) animal house of Jinnah Postgraduate Medical Center (JPMC). The animals were acclimatized for ten days at our animal house which is equipped with modern stainless steel cages with automatic parts for feeding and water drinking.
Animal housing
Animals housing was by the ethics guidelines of NIH and Ethics guidelines of the institute. Animals were acclimatized for ten days before the experiment. The animal was kept in stainless steel cages, which are equipped with automatic parts. The temperature was maintained at 23 ± 2°C. Dark -light cycles of 12 hours were strictly maintained for the experimental animals. We provide pellet diet and fresh clean water. Access to food and water was ad libitum.
Inclusion and exclusion criteria
Adult male Wistar rats of 8-12 weeks age of 170-200 grams were included. Sick, lazy male rats and female rats were the exclusion criteria.
Experimental design
80 male Wistar rats were randomly divided into a control and 3 experimental groups; Group A (n=20): Normal healthy rats taken as controls (0.9% saline water) Group B (n=20): Acetaminophen induced liver injury (2gram/kg bwt) daily [18] Group C (n=20): Acetaminophen (2gram/kg bwt) daily + Nacetyl cysteine (100 mg/kg bwt) for 21 days [5] Group D (n=20): Acetaminophen (2gram/kg bwt) daily + Berberine (100 mg/kg bwt) for 21 days. [19] 
Drugs and Chemicals
Acetaminophen (Panadol ®) was purchased from Glaxo Smith Kline, Pakistan. Berberine hydrochloride was purchased from China by Pharmacy Department. "Tweens 80" was purchased. It was used for formulation preparation in sterile H2O.
Berberine toxicity
To test the acute toxicity of Berberine hydrochloride, four rat groups were used; six rats in each group. Berberine hydrochloride was suspended in distilled water. It was given orally by gavages once daily for seven days at 200, 500, 1000, and 2000mg/kg doses. Rats were observed continuously on the first day and then twice for seven days. Toxicity was not observed up to maximum dose of 2000mg/kg. [19] Blood sampling Disposable syringes (BD, USA) were used for blood sampling by cardiac puncture after 18 hours of the post-experiment period. Blood samples were collected in gel tubes. Samples were incubated at 4000 rpm for 10 minutes to separate sera. The sera were stored at -200C for biochemical analysis. Any serum sample contaminated with blood was discarded immediately. [20] 
Biochemical testing
Liver function tests were performed spectrophotometrically using a commercial kit by standard methods on Roche Biochemical analyzer (Cobas e 411 analyzers, Roche Diagnostics GmbH, Mannheim, Germany). For Prothrombin time, a blood sample was taken in coagulation tubes and estimated by Humaclot duo using standard reagent kits of Merck. [21] Serum creatinine was measured by colorimetric Jaffé method. Superoxide dismutase, glutathione peroxidase, catalase, reduced glutathione (GSSH), and malondialdehyde (MDA) were detected by ELISA assay kit (Fortress Diagnostics) using standard methods mentioned in the literature. [22] [23] [24] 
Statistical analysis
The data was analyzed on Statistix 10.0 software (USA). One-way analysis of variance (ANOVA) was used for group comparisons followed by Bonferroni's test for multiple comparisons. Data was presented as mean, SD, and SEM. The confidence interval of statistical significance was defined at 95% (P≤ 0.05).
Results
Alanine transaminase, aspartate transaminase, alkaline phosphatase, lactate dehydrogenase, -glutamyl transferase, serum bilirubin and Prothrombin time (PT) are shown in Table 1 . Escape special TeX symbols (Compress whitespace Escape special TeX symbols (Compress whitespace Acetaminophen treated group B showed major rises in liver aminotransferases. NAC and BBR treated groups showed amelioration of cytoplasmic and mitochondrial enzymes. Amelioration of liver injury markers was more efficient in BBR treated animals than the NAC group (p = 0.0001). Markers of oxidative stress and lipid peroxidation were severely raised in acetaminophen-treated animals (group B). Group B animals showed elevated tissue MDA levels with a significant decrease in the SOD, GPX, CAT and GSSH compared to controls (p=0.0001). Markers of oxidative stress and lipid peroxidation of acetaminophen-induced liver injury were found significantly improved in rats treated with NAC and BBR drugs. The serum SOD, GPX, CAT, Scr and tissue SOD, GPX, CAT, GSSH, and tissue MDA showed statistically significant improvement as shown in Tables 2 and 3 . Escape special TeX symbols (Compress whitespace A rise in serum SOD, GPX, CAT and tissue SOD, GPX, CAT, GSSH with a decrease in MDA was noted in NAC, and BBR 
AAP -acetaminophen, NA-N-acetyl cysteine, BBR -Berberine

Discussion
Acetaminophen (AAP) induced liver toxicity was first reported in the United States in the mid-1980s, since then a rising trend has been reported from the World. AAP is one of the most commonly used drugs implicated in DILI. [1, 3, 4] A mortality of 0.4% has been reported, approximating 300 deaths per year in the USA. [2] AAP-induced liver injury is mediated through production of reactive oxygen species (ROS). [1, 25, 26] AAP, when taken in megadoses, is metabolized into N-acetyl p-benzoquinoneimine (NAPQI). The NAPQI is a highly reactive agent which induces liver injury by free radical formation. [27, 28] AAP induces oxidative stress and lipid peroxidation and depletes the liver of GSSH. [27] [28] [29] [30] In the present study, the Berberine was evaluated for its free radical scavenging activity in comparison to a standard drug; the N-acetyl cysteine (NAC). In our current study the hepatotoxicity due to acetaminophen was confirmed by elevated levels of biochemical parameters; like ALT, AST, ALP,γ -GT, PT and serum bilirubin in the experimental group. Acetaminophen treated group B showed a relentless rise in liver aminotransferases. The NAC and BBR treated groups showed amelioration of cytoplasmic and mitochondrial enzymes. The BBR treated animals showed more significant amelioration compared to NAC group (p = 0.0001). In the case of liver cell injury, the cytoplasmic and mitochondrial enzymes leak through the cell membrane, [31] and rise in the blood. [32] Treatment with NAC and BBR showed decreased levels of biochemical parameters; such as ALT, AST, ALP, γ -GT, PT, and serum bilirubin. This may be due to free radical scavenging activity of BBR and stabilization of cell membrane. Previous studies [30] [31] [32] [33] [34] supports the mechanisms. Serum ALP rises due to increased synthesis by the biliary canaliculi in response to biliary pressure because of cholestasis. [33, 34] The present study reports free radical scavenging activity of BBR and NAC as evaluated by markers of oxidation and peroxidation. The BBR treated rats showed a statistically significant rise in serum and tissue SOD, GPX, CAT and GSSH and a decline in MDA. Antioxidant and anti-lipid peroxidant effect of BBR was superior to the NAC. Our findings are in agreement with the previous studies. [35, 36] It is reported that the rise in MDA indicates failure of cellular antioxidant enzymes. [37] The BBR and NAC-treated rats showed a significant decrease in MDA; this suggests they possess antioxidant and anti peroxidant potential (Table 3 ). The BBR prevents hepatocyte cell injury by scavenging free radicals through an increase in cellular antioxidants -the SOD, GPX, CAT, and GSSH. The findings are in agreement with previous studies. [38, 39] The berberine mitigates the oxidative injury by raising the SOD, GPX, CAT and GSSH which is visibly evident in the present study.
Conclusion
The present study suggests a significant hepatoprotective effect of Berberine against acetaminophen-induced liver injury. The Berberine showed antioxidant and anti peroxidant potential.
Berberine increases the antioxidant enzymes activity -the superoxide dismutase, glutathione peroxidase, catalase and reduced glutathione, and decreases the malondialdehyde. The findings point towards free radical scavenging activity of Berberine.
